Methylxanthine Therapy for Apnea of Prematurity: Evaluation of Treatment Benefits and Risks at Age 5 Years in the International Caffeine for Apnea of Prematurity (CAP) Trial

Publisher： Karger

E-ISSN： 1661-7819|88|3|208-213

ISSN： 1661-7800

Source： Neonatology, Vol.88, Iss.3, 2005-09, pp. : 208-213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Caffeine for Apnea of Prematurity: A Neonatal Success Story

By  

Neonatology, Vol. 105, Iss. 4, 2014-05 ,pp. : 332-336

Karger

Access to resources Recommend Favorite

Doxapram Treatment for Apnea of Prematurity: A Systematic Review

By  

Neonatology, Vol. 111, Iss. 2, 2016-10 ,pp. : 162-171

Karger

Access to resources Recommend Favorite

Safety Profile Comparison between Extemporaneous and a Licensed Preparation of Caffeine Citrate in Preterm Infants with Apnea of Prematurity

By  

Neonatology, Vol. 105, Iss. 2, 2013-12 ,pp. : 108-111

Karger

Access to resources Recommend Favorite

Gastroesophageal Reflux and Apnea of Prematurity – Coincidence, Not Causation

By  

Neonatology, Vol. 103, Iss. 2, 2012-11 ,pp. : 103-104

Karger

Access to resources Recommend Favorite

Factors Influencing Apnea and Bradycardia of Prematurity – Implications for Neurodevelopment

By  

Neonatology, Vol. 91, Iss. 3, 2006-11 ,pp. : 155-161

Karger

Access to resources Recommend Favorite